Physician profile
Meara E Henley
NPI 1538319645
$1,895.25
in general payments reported to CMS, 2019-2025
12 companies · $351 in 2025
The $351 reported for 2025 was more than what 88% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $131 · 2022: $14.06 · 2023: $29.52 · 2024: $1,369 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,000 · Food and Beverage: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,000.00 |
| Food and Beverage | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $1,000.00 | 2024 | Ycanth |
| Novo Nordisk INC | $138.92 | 2024 | Wegovy |
| Alk-Abello, INC | $121.09 | 2024 | |
| Genzyme Corporation | $118.71 | 2025 | |
| Seqirus USA INC | $101.87 | 2024-2025 | |
| Gilead Sciences, INC. | $98.75 | 2021 | |
| Sanofi Pasteur INC. | $97.47 | 2021-2025 | |
| Glaxosmithkline, LLC. | $92.10 | 2025 | |
| Merck Sharp & Dohme LLC | $52.49 | 2023-2025 | Gardasil 9, Vaxneuvance, Proquad |
| Cranial Technologies, INC | $29.17 | 2022-2023 | Doc Band |
| Collegium Pharmaceutical, INC. | $26.27 | 2025 | Jornay Pm |
| Organon LLC | $18.41 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meara Henley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.